Zusammenfassung
Der systemische Lupus erythematodes ist eine systemische Autoimmunerkrankung, die durch die Produktion von zahlreichen Autoantikörpern, insbesondere antinukleären Antikörpern und Antikörpern gegen Doppelstrang-DNA, aber auch von Autoantikörpern gegen verschiedene Organe und Zellsysteme charakterisiert ist. Ätiologisch von Bedeutung sind sowohl Umwelteinflüsse, zu denen neben weiblichen Geschlechtshormonen und der UV-Strahlung auch Infektionen zu zählen sind, als auch eine genetische Prädisposition. Hier sind genetische Polymorphismen in Immunglobulin-Fc-Rezeptor-Genen, Komplementgenen, Zytokingenen und in Genen, die die Apoptose regulieren, zu nennen. Die Pathogenese ist gekennzeichnet durch eine Entzündung, die von Autoantikörpern, Immunkomplexen, aktivierten und autoreaktiven Lymphozyten geprägt und durch Ablagerung von Immunkomplexen, Komplementumsatz und zellulären Infiltraten in Geweben und Gefäßen charakterisiert ist. Die vorliegende Übersicht soll einen Einblick in aktuelle Konzepte zur Pathogenese des SLE geben.
Abstract
Systemic lupus erythematosus (SLE) is a systemic episodic autoimmune disease characterized by numerous autoantibodies, especially antinuclear antibodies and antibodies to double-strand DNA but also autoantibodies against various organs and cell systems. The heterogeneity of the clinical manifestations reflects the complexity of the disease’s pathogenesis. The aetiology is not completely understood, but environmental factors, including female sex hormones, ultraviolet light exposure and infections, play an important part, as does a genetic predisposition with genetic polymorphisms in immunoglobulin-Fc receptor genes, cytokine genes, complement genes and genes regulating apoptosis. The pathogenesis is linked with an inflammatory process involving autoantibodies, immune complexes and activated and autoreactive lymphocytes and is characterized by deposits of immune complexes, complement turnover and vascular and parenchymal cellular infiltrates in numerous tissues. This article reviews current concepts of the pathogenesis of SLE.
Literatur
Ackerman LS (2006) Sex hormones and the genesis of autoimmunity. Arch Dermatol 142: 371–376
Bennett L, Paluckaa AK, Arcee E et al. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197: 711–723
Bijl M, Reefman E, Horst G et al. (2006) Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis 65: 57–63
Chen YF, Morel L (2005) Genetics of T cell defects in lupus. Cell Mol Immunol 2: 403–409
Childs SG (2006) The pathogenesis of systemic lupus erythematosus. Orthop Nurs 25: 140–145
Criswell LA, Amos CI (2000) Update on genetic risk factors for systemic lupus erythematosus and rheumatoid arthritis. Curr Opin Rheumatol 12: 85–90
Crow MK, Kirou KA (2004) Interferon-α in systemic lupus erythematosus. Curr Opin Rheumatol 16: 541–547
Dean GS, Tyrrell-Price J, Crawley E et al. (2000) Cytokines and systemic lupus erythematosus. Ann Rheum Dis 59: 243–251
Dijstelbloem HM, Bijl M, Fijnheer R et al. (2000) Fcγ receptor polymorphisms in systemic lupus erythematosus: association with disease and in vivo clearance of immune complexes. Arthritis Rheum 43: 2793–2800
Doria A, Iaccarino L, Arienti S et al. (2006) Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol 22: 234–241
Gaipl US, Kuhn A, Sheriff A et al. (2006) Clearance of apoptotic cells in human SLE. Curr Dir Autoimmun 9: 173–187
Gattorno M, Picco P, Barbano G et al. (1998) Differences in tumor necrosis factor alpha soluble receptor serum concentrations between patients with Henoch-Schoenlein purpura and pediatric systemic lupus erythematosus. J Rheumatol 25: 361–365
Hagiwara E, Gourley MF, Lee S et al. (1996) Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: interferon-γ-secreting cells in the peripheral blood. Arthritis Rheum 39: 379–385
Kuhn A, Beissert S (2005) Photosensitivity in lupus erythematosus. Autoimmunity 38: 519–529
Kyttaris VC, Tsokos GC (2004) T lymphocytes in systemic lupus erythematosus: an update. Curr Opin Rheumatol 16: 548–552
Lee YJ, Shin KS, Kang SW et al. (2004) Association of the oestrogen receptor α gene polymorphisms with disease onset in systemic lupus erythematosus. Ann Rheum Dis 63: 1244–1249
Looney RJ, Anolik J, Sanz I (2004) B lymphocytes in systemic lupus erythematosus: lessions from therapy targeting B cells. Lupus 13: 1–10
Maddison PJ (1999) Nature and nurture in systemic lupus erythematosus. Adv Exp Med Biol 455: 7–13
Magnusson V, Nakken B, Bolstad AI et al. (2001) Cytokine polymorphisms in systemic lupus erythematosus and Sjögren’s syndrome. Scand J Immunol 54: 55–61
Manger K, Repp R, Jansen M et al. (2002) Fcγ receptor IIa, IIIa, and IIIb polymorphisms in German patients with systemic lupus erythematosus: association with clinical symptoms. Ann Rheum Dis 61: 786–792
Mason LJ, Isenberg DA (1998) Immunopathogenesis of SLE. Baillieres Clin Rheumatol 12: 385–403
Petri M, Robinson C (1997) Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 40: 797–803
Petty RE (1998) Etiology and pathogenesis of rheumatic diseases of adolescence. Adolesc Med 9: 11–24
Prokunina L, Alarcon-Riquelme M (2004) The genetic basis of systemic lupus erythematosus – knowledge of today and thoughts for tomorrow. Hum Mol Genet 13: R143–R148
Reveille JD (2005) Genetic studies in the rheumatic diseases: present status and implications for the future. J Rheumatol Suppl 72: 10–13
Singh AK (1993) Abnormalities in the regulation of variable region genes that encode for antibodies to DNA may be a central factor in the pathogenesis of systemic lupus erythematosus. Ann Rheum Dis 52: 378–383
Smyth LJC, Snowden N, Carthy D et al. (1997) Fcγ RIIa polymorphism in systemic lupus erythematosus. Ann Rheum Dis 56: 744–746
Tsao BP (2004) Update on human systemic lupus erythematosus genetics. Curr Opin Rheumatol 16: 513–521
Vaishnaw AK, McNally JD, Elkon KB (1997) Apoptosis in the rheumatic diseases. Arthritis Rheum 40: 1917–1927
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Horneff, G. Ätiopathogenese des systemischen Lupus erythematodes. Monatsschr Kinderheilkd 154, 1177–1188 (2006). https://doi.org/10.1007/s00112-006-1442-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00112-006-1442-0
Schlüsselwörter
- Systemischer Lupus erythematodes
- Autoimmunerkrankung
- Umwelteinflüsse
- Genetische Prädisposition
- Pathogenese